Dynamic Heavy Chain Antibody Libraries Using Flexible HVRs

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing antibody libraries face limitations in diversity and screening efficiency, particularly in identifying antibodies with desired properties due to constraints on sequence variety and practical screening capabilities.

Innovation Solution

Development of dynamic antibody libraries containing flexible HVR sequences, allowing for high diversity and efficient identification of antibodies with high affinity and cross-reactivity, using synthetic polynucleotides encoding HVR-H1, HVR-H2, and HVR-H3 regions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If traditional antibody libraries are constructed from biological sources or synthesized, then sequence diversity is achieved, but library size is limited and screening becomes time-consuming and laborious

Engineering Contradiction:
Improvesequence diversityVSAvoidscreening time
Core Design Contradiction:
Quantity of substanceVSLoss of time

Solution Approach 1:

The patent applies parameter changes by systematically varying the HVR sequences according to defined formulas with specific amino acid constraints (e.g., X1 is F or Y, X2 is S or T, etc.). This allows generation of diverse antibody sequences with controlled variability, achieving high sequence diversity while maintaining manageable library sizes that can be efficiently screened.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces dynamic units with flexible HVR sequences that can adopt multiple conformations. This dynamic approach allows the antibody libraries to explore a broader sequence space without proportionally increasing library size, thereby reducing screening time while maintaining diversity.

Inventive Principle:
Principle #15Dynamics

2Quantity of substance

If library size is increased to improve diversity, then more antibody variants are available, but screening efficiency decreases and becomes more exhaustive

Engineering Contradiction:
Improvelibrary diversityVSAvoidscreening efficiency
Core Design Contradiction:
Quantity of substanceVSProductivity

Solution Approach 1:

By controlling the parameter space of HVR sequences through defined formulas with specific amino acid options at each position, the patent generates high diversity within a constrained framework. This allows creation of compact libraries that maintain broad diversity while remaining feasible for efficient screening.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent segments the antibody sequence into fixed framework regions and variable HVR regions. By applying formulas specifically to the HVR segments with controlled variability, diversity is concentrated where it matters most (binding specificity) while keeping the overall library size manageable for efficient screening.

Inventive Principle:
Principle #1Segmentation

3Adaptability or versatility

If HVR sequences are made flexible to recognize multiple epitopes, then binding versatility improves, but library complexity increases

Engineering Contradiction:
Improveepitope recognition capabilityVSAvoidlibrary complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent uses parameter changes by defining specific amino acid constraints in HVR formulas (e.g., X1 is F or Y, X3 is D, G, N, or S) that promote flexibility and conformational diversity. This enables antibodies to recognize multiple epitope types including conformational epitopes, while the constrained parameter space prevents exponential library complexity expansion.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS12385162B2Dynamic human heavy chain antibody libraries
Publication Date: 2025.08.12 ADAGENE INC
  • US12385162B2 patent drawing
  • US12385162B2 patent drawing
  • US12385162B2 patent drawing

AI summary

Provided herein are libraries containing polynucleotides, where one of the polynucleotides encodes an antibody heavy chain with specific hypervariable regions HVR-H1 and HVR-H2. Further provided herein are libraries containing polynucleotides encoding a plurality of unique antibodies, wherein each antibody comprises a heavy chain variable region and a light chain variable region. Also provided are antibodies, polypeptide libraries, vector libraries, cells, non-human animals, antibody heavy chains, methods of making an antibody library, kits, and methods of generating a bispecific antibody related thereto.